Aromatic Amino Acid Decarboxylation Inhibitor [EPC]

Aromatic Amino Acid Decarboxylation Inhibitor [EPC] was reported 28256 times

Drugs of the Aromatic Amino Acid Decarboxylation Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PARKINSONISM HYPERPYREXIA SYNDROME 30 0.1676
1 DOPAMINE DYSREGULATION SYNDROME 74 0.1659
2 PARKINSONIAN CRISIS 17 0.1650
3 FREEZING PHENOMENON 553 0.1492
4 DEEP BRAIN STIMULATION 88 0.1457
5 ON AND OFF PHENOMENON 800 0.1440
6 CATHETER SITE NODULE 26 0.1361
7 BENIGN NEOPLASM OF ADRENAL GLAND 20 0.1333
8 PATHOLOGICAL GAMBLING 221 0.1331
9 STOMA SITE ERYTHEMA 247 0.1321
10 STOMA SITE ODOUR 29 0.1295
11 PARKINSON'S DISEASE 318 0.1250
12 STOMA SITE HYPERGRANULATION 76 0.1204
13 STOMA SITE IRRITATION 65 0.1195
14 JEALOUS DELUSION 31 0.1095
15 CATHETER SITE INDURATION 21 0.1088
16 STOMA SITE DISCHARGE 285 0.1040
17 STOMA SITE PAIN 152 0.1034
18 SUPINE HYPERTENSION 19 0.1005
19 REDUCED FACIAL EXPRESSION 101 0.0995
20 STOMA SITE DISCOMFORT 22 0.0969
21 STOMA SITE REACTION 65 0.0949
22 VITAMIN B6 DEFICIENCY 23 0.0935
23 VASCULAR ENCEPHALOPATHY 25 0.0880
24 STOMA SITE INFECTION 113 0.0868
25 STOMA SITE EXTRAVASATION 33 0.0855
26 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 32 0.0796
27 EUTHANASIA 24 0.0757
28 MULTIPLE SYSTEM ATROPHY 26 0.0739
29 SALIVA DISCOLOURATION 23 0.0689
30 HYPERSEXUALITY 122 0.0667
31 BRADYKINESIA 387 0.0655
32 STOMA SITE INFLAMMATION 48 0.0643
33 PARKINSONIAN GAIT 40 0.0641
34 PATIENT ELOPEMENT 23 0.0628
35 FIBROMA 56 0.0609
36 DEMENTIA WITH LEWY BODIES 61 0.0548
37 DEVICE COLOUR ISSUE 22 0.0545
38 CATHETER SITE BRUISE 18 0.0544
39 HYPERKINESIA 105 0.0495
40 STOMA SITE HAEMORRHAGE 71 0.0461
41 MEDICAL DEVICE CHANGE 24 0.0450
42 MUSCLE RIGIDITY 535 0.0447
43 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 45 0.0447
44 SLEEP ATTACKS 20 0.0420
45 DYSKINESIA 1704 0.0419
46 ENTERAL NUTRITION 24 0.0414
47 IMPULSE-CONTROL DISORDER 84 0.0408
48 GAMBLING 47 0.0403
49 SUSPICIOUSNESS 28 0.0398
50 COMPULSIONS 26 0.0390
51 YAWNING 104 0.0390
52 THERAPEUTIC PRODUCT EFFECT VARIABLE 151 0.0389
53 COMPULSIVE SHOPPING 77 0.0374
54 HALLUCINATION 2711 0.0359
55 DELUSION 551 0.0354
56 SUDDEN ONSET OF SLEEP 48 0.0346
57 CEREBRAL HYPOPERFUSION 16 0.0343
58 DEVICE ALARM ISSUE 62 0.0341
59 HALLUCINATION, VISUAL 720 0.0341
60 DEVICE LOOSENING 29 0.0335
61 AKINESIA 69 0.0333
62 SALIVA ALTERED 28 0.0311
63 POSTURE ABNORMAL 101 0.0310
64 LIBIDO INCREASED 62 0.0305
65 MEDICAL DEVICE SITE PAIN 17 0.0302
66 HALLUCINATION, TACTILE 20 0.0300
67 PRODUCT RESIDUE PRESENT 162 0.0300
68 CATHETER SITE RELATED REACTION 22 0.0293
69 RESTING TREMOR 18 0.0279
70 NONSPECIFIC REACTION 152 0.0277
71 FEAR OF FALLING 22 0.0270
72 STOMA COMPLICATION 27 0.0266
73 RADIOISOTOPE SCAN ABNORMAL 18 0.0255
74 REHABILITATION THERAPY 98 0.0253
75 DEVICE CONNECTION ISSUE 53 0.0251
76 LIVING IN RESIDENTIAL INSTITUTION 46 0.0245
77 DELUSIONAL DISORDER, UNSPECIFIED TYPE 18 0.0241
78 OBSESSIVE-COMPULSIVE DISORDER 192 0.0239
79 DEVICE KINK 87 0.0239
80 INFUSION SITE NODULE 22 0.0229
81 PARKINSONISM 206 0.0211
82 BLADDER CATHETERISATION 20 0.0206
83 SLEEP TALKING 35 0.0206
84 HALLUCINATIONS, MIXED 86 0.0204
85 ANTICHOLINERGIC SYNDROME 32 0.0201
86 DEVICE OCCLUSION 275 0.0195
87 UTERINE PROLAPSE 21 0.0193
88 CHOREA 32 0.0186
89 TENSION 113 0.0185
90 DYSTONIA 344 0.0177
91 ILLUSION 29 0.0175
92 INFUSION SITE MASS 19 0.0175
93 COGWHEEL RIGIDITY 18 0.0171
94 SUBILEUS 35 0.0168
95 DROOLING 115 0.0166
96 ORTHOSTATIC HYPOTENSION 282 0.0162
97 DEMENTIA 451 0.0161
98 FINE MOTOR SKILL DYSFUNCTION 46 0.0159
99 INFUSION SITE INDURATION 23 0.0155
100 PERSECUTORY DELUSION 38 0.0152
101 IMPULSIVE BEHAVIOUR 57 0.0152
102 CATHETER SITE DISCHARGE 17 0.0151
103 GASTROSTOMY 23 0.0148
104 AORTIC VALVE INCOMPETENCE 63 0.0148
105 NOCTURIA 177 0.0146
106 GAMBLING DISORDER 38 0.0141
107 FAECALOMA 77 0.0140
108 CATHETER SITE ERYTHEMA 30 0.0140
109 DISTRACTIBILITY 16 0.0139
110 DYSCHEZIA 42 0.0137
111 FEELING GUILTY 18 0.0136
112 NASAL DISCHARGE DISCOLOURATION 18 0.0130
113 THERAPEUTIC PRODUCT EFFECT DELAYED 59 0.0129
114 PARANOIA 221 0.0128
115 FLUID INTAKE REDUCED 63 0.0126
116 NEUROLEPTIC MALIGNANT SYNDROME 147 0.0124
117 BEZOAR 17 0.0123
118 COMMUNICATION DISORDER 47 0.0123
119 STARING 29 0.0120
120 TERMINAL INSOMNIA 21 0.0119
121 TORTICOLLIS 25 0.0118
122 HYPERPHAGIA 47 0.0118
123 INFUSION SITE INFECTION 27 0.0116
124 CEREBRAL ATROPHY 46 0.0115
125 HEART VALVE REPLACEMENT 17 0.0115
126 APRAXIA 17 0.0115
127 SLOW SPEECH 27 0.0111
128 ABNORMAL BEHAVIOUR 439 0.0111
129 AUTONOMIC NERVOUS SYSTEM IMBALANCE 32 0.0109
130 HYPOKINESIA 159 0.0109
131 BEHAVIOUR DISORDER 59 0.0109
132 PRESCRIBED UNDERDOSE 216 0.0108
133 CATHETER SITE PAIN 28 0.0108
134 IMMOBILE 47 0.0108
135 INFUSION SITE BRUISING 23 0.0106
136 ABNORMAL DREAMS 291 0.0105
137 SPEECH DISORDER 541 0.0103
138 WHEELCHAIR USER 45 0.0101
139 SALIVARY HYPERSECRETION 100 0.0100
140 CONFUSIONAL STATE 1593 0.0098
141 MEDICAL DEVICE DISCOMFORT 30 0.0098
142 PNEUMONIA ASPIRATION 242 0.0097
143 MOTOR DYSFUNCTION 98 0.0096
144 PSYCHOTIC DISORDER 284 0.0096
145 INTENTIONAL UNDERDOSE 70 0.0096
146 TREMOR 1580 0.0095
147 INFUSION SITE REACTION 28 0.0094
148 VITAMIN B12 DECREASED 27 0.0094
149 RESTLESS LEGS SYNDROME 170 0.0093
150 MOVEMENT DISORDER 296 0.0092
151 GASTROINTESTINAL TUBE INSERTION 23 0.0092
152 BRADYPHRENIA 60 0.0092
153 HOSPICE CARE 90 0.0091
154 HIP FRACTURE 293 0.0091
155 METABOLIC ENCEPHALOPATHY 27 0.0090
156 CATATONIA 47 0.0089
157 DYSSTASIA 260 0.0089
158 BLOOD SODIUM INCREASED 24 0.0089
159 INFREQUENT BOWEL MOVEMENTS 22 0.0088
160 TERMINAL STATE 59 0.0088
161 DEVICE DISLOCATION 381 0.0088
162 FAECES HARD 34 0.0087
163 COGNITIVE DISORDER 408 0.0087
164 GAIT INABILITY 291 0.0087
165 IMPAIRED SELF-CARE 18 0.0087
166 PRODUCT CLEANING INADEQUATE 23 0.0086
167 AGGRESSION 429 0.0086
168 SLEEP DEFICIT 18 0.0085
169 MASTICATION DISORDER 26 0.0085
170 SCREAMING 54 0.0085
171 DECUBITUS ULCER 69 0.0085
172 VOLVULUS 20 0.0084
173 FACE INJURY 32 0.0084
174 INCONTINENCE 88 0.0083
175 DECREASED INTEREST 49 0.0083
176 INITIAL INSOMNIA 85 0.0083
177 DELIRIUM 286 0.0082
178 BALANCE DISORDER 704 0.0081
179 UNRESPONSIVE TO STIMULI 210 0.0081
180 HYPOPHAGIA 208 0.0081
181 FALL 2690 0.0081
182 MOBILITY DECREASED 573 0.0080
183 CHOKING 153 0.0078
184 TRICUSPID VALVE INCOMPETENCE 62 0.0078
185 BENIGN PROSTATIC HYPERPLASIA 40 0.0077
186 FAILURE TO THRIVE 40 0.0077
187 BOWEL MOVEMENT IRREGULARITY 59 0.0077
188 AGITATION 565 0.0077
189 PRODUCT PACKAGING DIFFICULT TO OPEN 20 0.0077
190 RESTLESSNESS 280 0.0076
191 CLAVICLE FRACTURE 29 0.0076
192 THERAPEUTIC RESPONSE SHORTENED 251 0.0076
193 ABNORMAL FAECES 62 0.0076
194 DISORIENTATION 298 0.0075
195 DRUG EFFECT DELAYED 34 0.0075
196 ASPIRATION 82 0.0075
197 POOR QUALITY SLEEP 160 0.0074
198 INCOHERENT 48 0.0074
199 BLOOD CHLORIDE DECREASED 19 0.0074
200 MIDDLE INSOMNIA 136 0.0073
201 HYPERSOMNIA 208 0.0072
202 ABDOMINAL TENDERNESS 36 0.0072
203 GAIT DISTURBANCE 1385 0.0072
204 CATHETER SITE HAEMORRHAGE 18 0.0072
205 NEGATIVE THOUGHTS 21 0.0072
206 DYSGRAPHIA 47 0.0071
207 SLEEP TERROR 30 0.0071
208 GASTROINTESTINAL SOUNDS ABNORMAL 35 0.0071
209 PSYCHOMOTOR HYPERACTIVITY 117 0.0070
210 DIFFICULTY IN WALKING 24 0.0070
211 TRISMUS 36 0.0070
212 NIGHTMARE 240 0.0069
213 HYPERTONIC BLADDER 20 0.0069
214 DYSPHAGIA 638 0.0067
215 SOPOR 89 0.0067
216 WALKING AID USER 44 0.0067
217 SOMNOLENCE 1341 0.0067
218 HALLUCINATION, AUDITORY 105 0.0066
219 HEAD INJURY 209 0.0066
220 ANXIETY DISORDER 22 0.0066
221 MICTURITION URGENCY 75 0.0066
222 LOGORRHOEA 23 0.0065
223 DEVICE POWER SOURCE ISSUE 19 0.0065
224 DEVICE ISSUE 582 0.0065
225 ACUTE PSYCHOSIS 16 0.0065
226 DEVICE USE ISSUE 113 0.0065
227 PANIC DISORDER 25 0.0064
228 SKIN LACERATION 70 0.0064
229 DIZZINESS POSTURAL 62 0.0064
230 CERVICAL VERTEBRAL FRACTURE 22 0.0064
231 MUSCULOSKELETAL STIFFNESS 553 0.0063
232 PERSONALITY CHANGE 58 0.0062
233 MITRAL VALVE INCOMPETENCE 70 0.0062
234 LUMBAR SPINAL STENOSIS 18 0.0062
235 DEVICE PLACEMENT ISSUE 22 0.0061
236 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292 0.0061
237 BLOOD PRESSURE FLUCTUATION 145 0.0060
238 EMBEDDED DEVICE 59 0.0060
239 APHASIA 179 0.0059
240 SKIN ABRASION 28 0.0059
241 HYPERVENTILATION 34 0.0059
242 CLUMSINESS 16 0.0059
243 FEMORAL NECK FRACTURE 30 0.0058
244 BLADDER DISORDER 58 0.0058
245 SPINAL STENOSIS 24 0.0058
246 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
247 PELVIC FRACTURE 45 0.0058
248 BRUXISM 31 0.0057
249 DYSARTHRIA 216 0.0057
250 APPLICATION SITE REACTION 40 0.0057
251 URINARY INCONTINENCE 168 0.0057
252 PROSTATOMEGALY 22 0.0056
253 SPUTUM DISCOLOURED 53 0.0056
254 SOMNAMBULISM 36 0.0055
255 URINARY TRACT INFECTION 934 0.0055
256 ANAL INCONTINENCE 49 0.0054
257 SPINAL OSTEOARTHRITIS 47 0.0053
258 INFUSION SITE ERYTHEMA 45 0.0053
259 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 374 0.0053
260 HAEMORRHAGIC ANAEMIA 23 0.0052
261 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
262 DEVICE PHYSICAL PROPERTY ISSUE 40 0.0052
263 RIB FRACTURE 106 0.0051
264 ILEUS 64 0.0051
265 TEARFULNESS 22 0.0051
266 EATING DISORDER 108 0.0051
267 GENERAL SYMPTOM 38 0.0051
268 CEREBRAL HAEMATOMA 17 0.0051
269 BEDRIDDEN 66 0.0050
270 PRODUCT AVAILABILITY ISSUE 114 0.0050
271 FACIAL BONES FRACTURE 18 0.0050
272 UROSEPSIS 46 0.0050
273 SLUGGISHNESS 50 0.0049
274 FEEDING DISORDER 99 0.0049
275 MALNUTRITION 54 0.0048
276 CYTOLYTIC HEPATITIS 16 0.0048
277 BLOOD PRESSURE DECREASED 316 0.0048
278 ECONOMIC PROBLEM 71 0.0047
279 HYPOMANIA 17 0.0046
280 HYPERNATRAEMIA 23 0.0046
281 SLEEP DISORDER 325 0.0046
282 HEAD DISCOMFORT 81 0.0046
283 PANIC REACTION 33 0.0046
284 CHOKING SENSATION 25 0.0045
285 DEPRESSED MOOD 238 0.0045
286 CATHETER SITE INFECTION 17 0.0045
287 PRODUCT COLOUR ISSUE 23 0.0045
288 PARALYSIS 64 0.0045
289 MANIA 73 0.0044
290 MENTAL STATUS CHANGES 123 0.0044
291 SEROTONIN SYNDROME 85 0.0044
292 WRIST FRACTURE 53 0.0044
293 CONSTIPATION 958 0.0044
294 PRESCRIBED OVERDOSE 85 0.0044
295 HAND FRACTURE 31 0.0044
296 HYPERTONIA 25 0.0044
297 ABASIA 107 0.0043
298 APATHY 63 0.0043
299 DRUG EFFECT LESS THAN EXPECTED 64 0.0043
300 REFUSAL OF TREATMENT BY PATIENT 28 0.0043
301 SPINAL COLUMN STENOSIS 20 0.0042
302 SPINAL COMPRESSION FRACTURE 35 0.0042
303 FRUSTRATION TOLERANCE DECREASED 34 0.0042
304 CARDIAC VALVE DISEASE 24 0.0042
305 DIPLOPIA 109 0.0042
306 MEMORY IMPAIRMENT 574 0.0042
307 SYNCOPE 418 0.0042
308 THERAPEUTIC PRODUCT EFFECT DECREASED 187 0.0042
309 UNEVALUABLE EVENT 315 0.0042
310 URINARY RETENTION 138 0.0041
311 FEAR 111 0.0041
312 DYSPHEMIA 18 0.0041
313 DEPRESSED LEVEL OF CONSCIOUSNESS 162 0.0041
314 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 17 0.0041
315 TROPONIN INCREASED 31 0.0041
316 ANURIA 35 0.0041
317 SUBDURAL HAEMATOMA 58 0.0040
318 LOSS OF CONSCIOUSNESS 516 0.0040
319 MUSCLE TWITCHING 92 0.0040
320 DRUG INTERACTION 633 0.0040
321 LEFT VENTRICULAR HYPERTROPHY 17 0.0040
322 BLEPHAROSPASM 25 0.0040
323 SUDDEN DEATH 42 0.0040
324 PHARMACEUTICAL PRODUCT COMPLAINT 103 0.0040
325 MENTAL IMPAIRMENT 96 0.0040
326 MUSCLE TIGHTNESS 64 0.0039
327 EYE MOVEMENT DISORDER 27 0.0039
328 HYPOVOLAEMIA 23 0.0039
329 APPETITE DISORDER 26 0.0039
330 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17 0.0039
331 CEREBRAL ISCHAEMIA 20 0.0039
332 FORMICATION 27 0.0039
333 LIMB DISCOMFORT 120 0.0039
334 PRODUCT PHYSICAL ISSUE 78 0.0039
335 GRANULOCYTOPENIA 22 0.0039
336 DEFAECATION URGENCY 27 0.0038
337 GENERAL PHYSICAL CONDITION ABNORMAL 26 0.0038
338 MALABSORPTION 20 0.0038
339 SENSORY DISTURBANCE 61 0.0038
340 DECREASED ACTIVITY 41 0.0038
341 COORDINATION ABNORMAL 53 0.0038
342 HYPERTHERMIA 29 0.0038
343 FOOT DEFORMITY 42 0.0038
344 PANIC ATTACK 138 0.0038
345 HYPERLIPIDAEMIA 45 0.0038
346 GENERAL PHYSICAL HEALTH DETERIORATION 434 0.0037
347 SCOLIOSIS 23 0.0037
348 LETHARGY 210 0.0036
349 THINKING ABNORMAL 68 0.0036
350 ACTIVITIES OF DAILY LIVING IMPAIRED 72 0.0036
351 LACERATION 34 0.0036
352 MUSCLE STRAIN 31 0.0036
353 TRANSIENT ISCHAEMIC ATTACK 120 0.0036
354 HYPOTENSION 713 0.0036
355 DRY MOUTH 287 0.0035
356 SUBARACHNOID HAEMORRHAGE 36 0.0035
357 ANOSMIA 51 0.0035
358 PSYCHIATRIC SYMPTOM 26 0.0035
359 LOWER GASTROINTESTINAL HAEMORRHAGE 26 0.0035
360 HIP SURGERY 19 0.0035
361 INFUSION SITE SWELLING 22 0.0035
362 INFUSION SITE PAIN 45 0.0035
363 DISTURBANCE IN ATTENTION 188 0.0035
364 NERVOUSNESS 181 0.0035
365 SOCIAL AVOIDANT BEHAVIOUR 20 0.0035
366 INGUINAL HERNIA 21 0.0034
367 MOOD ALTERED 94 0.0034
368 AFFECTIVE DISORDER 27 0.0034
369 CARDIOMEGALY 42 0.0034
370 UPPER LIMB FRACTURE 68 0.0034
371 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35 0.0034
372 BLOOD UREA INCREASED 57 0.0034
373 THERAPEUTIC RESPONSE UNEXPECTED 152 0.0034
374 MUSCULAR WEAKNESS 385 0.0034
375 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 58 0.0034
376 ENCEPHALOPATHY 83 0.0034
377 COLITIS MICROSCOPIC 16 0.0034
378 DRUG EFFECT DECREASED 179 0.0033
379 CACHEXIA 17 0.0033
380 INSOMNIA 880 0.0033
381 UNINTENTIONAL MEDICAL DEVICE REMOVAL 38 0.0033
382 MAJOR DEPRESSION 24 0.0033
383 ANXIETY 934 0.0033
384 MYOCLONUS 39 0.0033
385 MUSCULOSKELETAL DISORDER 62 0.0033
386 CONDITION AGGRAVATED 985 0.0032
387 PRODUCT USE COMPLAINT 51 0.0032
388 POLLAKIURIA 135 0.0032
389 HYPERHIDROSIS 417 0.0032
390 ALTERED STATE OF CONSCIOUSNESS 70 0.0032
391 ENERGY INCREASED 19 0.0032
392 PRESYNCOPE 78 0.0032
393 CARDIAC PACEMAKER INSERTION 19 0.0032
394 PEMPHIGOID 24 0.0032
395 CORONAVIRUS INFECTION 21 0.0032
396 PRODUCT COMMUNICATION ISSUE 28 0.0032
397 DEVICE DIFFICULT TO USE 210 0.0032
398 SPINAL OPERATION 39 0.0032
399 FEELING ABNORMAL 758 0.0032
400 CHROMATURIA 71 0.0031
401 EXTRAPYRAMIDAL DISORDER 78 0.0031
402 UNDERDOSE 229 0.0031
403 PYELONEPHRITIS 27 0.0031
404 ANGER 105 0.0031
405 ATELECTASIS 30 0.0031
406 SEDATION 81 0.0031
407 HIATUS HERNIA 40 0.0031
408 MUSCLE DISORDER 25 0.0031
409 PRE-EXISTING CONDITION IMPROVED 19 0.0030
410 FEELING JITTERY 58 0.0030
411 ASTHENIA 1143 0.0030
412 SLEEP APNOEA SYNDROME 58 0.0030
413 ATAXIA 36 0.0030
414 COMPLICATION ASSOCIATED WITH DEVICE 44 0.0030
415 EUPHORIC MOOD 31 0.0030
416 PRODUCT DOSE OMISSION 197 0.0030
417 DYSPHONIA 176 0.0030
418 OROPHARYNGEAL DISCOMFORT 27 0.0030
419 MENTAL DISORDER 130 0.0030
420 DIZZINESS 1484 0.0030
421 HAEMATOCRIT DECREASED 59 0.0030
422 CONCUSSION 23 0.0030
423 PRODUCT ADMINISTRATION ERROR 60 0.0030
424 COLITIS ISCHAEMIC 20 0.0030
425 WEIGHT DECREASED 825 0.0030
426 DEHYDRATION 393 0.0029
427 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
428 TARDIVE DYSKINESIA 83 0.0029
429 INTERNATIONAL NORMALISED RATIO INCREASED 83 0.0029
430 HYPERTENSIVE CRISIS 32 0.0029
431 CATARACT OPERATION 17 0.0029
432 RENAL FAILURE CHRONIC 22 0.0029
433 BLOOD CREATINE PHOSPHOKINASE INCREASED 82 0.0028
434 PHOTOPSIA 18 0.0028
435 DEVICE BREAKAGE 115 0.0028
436 QUALITY OF LIFE DECREASED 38 0.0028
437 ADVERSE DRUG REACTION 253 0.0028
438 SEXUAL DYSFUNCTION 33 0.0028
439 OEDEMA PERIPHERAL 343 0.0028
440 PRODUCT DISTRIBUTION ISSUE 26 0.0028
441 AKATHISIA 38 0.0028
442 DEPRESSION 633 0.0028
443 PERIPHERAL COLDNESS 38 0.0028
444 BLOOD PRESSURE ABNORMAL 55 0.0028
445 EYELID PTOSIS 28 0.0028
446 NEUTROPHIL COUNT INCREASED 28 0.0027
447 SENSORY LOSS 22 0.0027
448 PERIPHERAL SWELLING 421 0.0027
449 IMPAIRED DRIVING ABILITY 31 0.0027
450 MYOCARDIAL ISCHAEMIA 31 0.0027
451 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
452 RESPIRATORY RATE INCREASED 24 0.0027
453 BLOOD IRON DECREASED 32 0.0027
454 DUODENAL ULCER 19 0.0027
455 SINUS BRADYCARDIA 26 0.0027
456 MALIGNANT MELANOMA 36 0.0027
457 DIVERTICULUM 19 0.0027
458 RETCHING 57 0.0027
459 ORAL DISCOMFORT 37 0.0027
460 PRODUCT SUPPLY ISSUE 19 0.0027
461 DRY THROAT 27 0.0027
462 ANOREXIA 34 0.0026
463 CYSTITIS 84 0.0026
464 TONGUE DISORDER 19 0.0026
465 DENTAL CARIES 29 0.0026
466 BODY HEIGHT DECREASED 28 0.0026
467 MUSCLE ATROPHY 33 0.0026
468 WEIGHT FLUCTUATION 27 0.0026
469 LIMB INJURY 70 0.0026
470 CARPAL TUNNEL SYNDROME 36 0.0026
471 HYPOTHERMIA 26 0.0026
472 DEVICE LEAKAGE 111 0.0026
473 FEELING DRUNK 19 0.0026
474 ELECTROCARDIOGRAM ABNORMAL 20 0.0025
475 THERMAL BURN 18 0.0025
476 EMOTIONAL DISORDER 78 0.0025
477 NASAL DISCOMFORT 20 0.0025
478 RHABDOMYOLYSIS 105 0.0025
479 POLYNEUROPATHY 30 0.0025
480 POST PROCEDURAL COMPLICATION 48 0.0025
481 ACUTE RESPIRATORY FAILURE 48 0.0025
482 ABNORMAL LOSS OF WEIGHT 17 0.0025
483 BLOOD SODIUM DECREASED 47 0.0025
484 COUGH 698 0.0025
485 TREATMENT NONCOMPLIANCE 135 0.0025
486 JOINT DISLOCATION 26 0.0025
487 CEREBRAL HAEMORRHAGE 88 0.0025
488 HYPOMAGNESAEMIA 34 0.0024
489 MUSCLE SPASMS 444 0.0024
490 ADVERSE EVENT 221 0.0024
491 BIPOLAR DISORDER 26 0.0024
492 PULMONARY THROMBOSIS 26 0.0024
493 COLD SWEAT 42 0.0024
494 ATRIAL FLUTTER 19 0.0024
495 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 111 0.0024
496 CRYING 86 0.0024
497 FEMUR FRACTURE 73 0.0024
498 WRONG DRUG ADMINISTERED 21 0.0024
499 PALLOR 64 0.0023
500 PROCEDURAL COMPLICATION 18 0.0023
501 SQUAMOUS CELL CARCINOMA 22 0.0023
502 CONTUSION 224 0.0023
503 ATRIAL FIBRILLATION 226 0.0023
504 BLOOD PRESSURE INCREASED 354 0.0023
505 VENTRICULAR EXTRASYSTOLES 24 0.0023
506 HYPOTONIA 23 0.0023
507 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
508 DECREASED APPETITE 532 0.0023
509 HYPONATRAEMIA 129 0.0023
510 LOWER LIMB FRACTURE 44 0.0023
511 IRON DEFICIENCY ANAEMIA 21 0.0023
512 IMPAIRED GASTRIC EMPTYING 31 0.0023
513 ACUTE MYOCARDIAL INFARCTION 67 0.0023
514 SUICIDAL IDEATION 208 0.0023
515 INTESTINAL OBSTRUCTION 85 0.0023
516 JOINT INJURY 48 0.0022
517 AMNESIA 146 0.0022
518 JOINT RANGE OF MOTION DECREASED 30 0.0022
519 GLAUCOMA 43 0.0022
520 HIP ARTHROPLASTY 34 0.0022
521 SPINAL DISORDER 21 0.0022
522 OSTEOARTHRITIS 94 0.0022
523 WRONG TECHNIQUE IN DRUG USAGE PROCESS 80 0.0022
524 ANKLE FRACTURE 34 0.0022
525 SPINAL FRACTURE 44 0.0022
526 CARDIAC MURMUR 19 0.0022
527 BRAIN INJURY 22 0.0022
528 SMALL INTESTINAL OBSTRUCTION 27 0.0022
529 ILL-DEFINED DISORDER 133 0.0022
530 SCRATCH 23 0.0022
531 ROTATOR CUFF SYNDROME 28 0.0022
532 NEURALGIA 53 0.0022
533 INCORRECT DOSE ADMINISTERED BY DEVICE 57 0.0022
534 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
535 SEPSIS 242 0.0022
536 TOOTH EXTRACTION 27 0.0022
537 BRAIN FOG 34 0.0022
538 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
539 HEART RATE IRREGULAR 49 0.0022
540 HEART RATE DECREASED 76 0.0022
541 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
542 APPLICATION SITE PRURITUS 49 0.0022
543 OSTEOMYELITIS 39 0.0022
544 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
545 RENAL CYST 17 0.0021
546 SENSATION OF FOREIGN BODY 18 0.0021
547 DEATH 1830 0.0021
548 THROAT IRRITATION 95 0.0021
549 PULMONARY HYPERTENSION 44 0.0021
550 FACIAL PARALYSIS 18 0.0021
551 VITAMIN D DECREASED 18 0.0021
552 PROSTATIC SPECIFIC ANTIGEN INCREASED 29 0.0021
553 HYPOXIA 74 0.0021
554 BLOOD POTASSIUM DECREASED 63 0.0021
555 INJECTION SITE NODULE 23 0.0021
556 FEELING COLD 58 0.0021
557 EXOSTOSIS 19 0.0021
558 PNEUMONIA 673 0.0021
559 FAECES DISCOLOURED 45 0.0021
560 NODULE 27 0.0021
561 MUSCULOSKELETAL CHEST PAIN 32 0.0021
562 PRODUCT DISPENSING ERROR 45 0.0021
563 HEMIPARESIS 35 0.0021
564 PRODUCT DOSE OMISSION ISSUE 607 0.0021
565 PRODUCT PRESCRIBING ERROR 49 0.0021
566 RESPIRATORY DISORDER 61 0.0020
567 MEDICATION ERROR 113 0.0020
568 ARTERIOSCLEROSIS 19 0.0020
569 IMPAIRED QUALITY OF LIFE 29 0.0020
570 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
571 IRRITABILITY 121 0.0020
572 AGEUSIA 50 0.0020
573 BRADYCARDIA 106 0.0020
574 CARDIAC FAILURE CONGESTIVE 159 0.0020
575 CYANOSIS 31 0.0020
576 DRUG INEFFECTIVE 2586 0.0020
577 RESPIRATORY FAILURE 143 0.0020
578 MALAISE 860 0.0020
579 ADVERSE REACTION 26 0.0020
580 SEIZURE 226 0.0020
581 CORONARY ARTERY DISEASE 59 0.0019
582 MOOD SWINGS 62 0.0019
583 FEELING HOT 119 0.0019
584 ABDOMINAL DISTENSION 202 0.0019
585 NECK PAIN 108 0.0019
586 HAEMATOMA 50 0.0019
587 DRUG EFFECT INCOMPLETE 70 0.0019
588 INTERNAL HAEMORRHAGE 22 0.0019
589 CEREBROVASCULAR ACCIDENT 325 0.0019
590 WOUND INFECTION 21 0.0019
591 SECRETION DISCHARGE 24 0.0019
592 BLOOD POTASSIUM INCREASED 31 0.0019
593 MELAENA 42 0.0019
594 DYSURIA 70 0.0019
595 HAEMATURIA 65 0.0019
596 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
597 THERAPEUTIC RESPONSE DECREASED 115 0.0019
598 RESPIRATORY DISTRESS 52 0.0019
599 SCIATICA 30 0.0019
600 CLOSTRIDIUM DIFFICILE INFECTION 41 0.0019
601 HAEMORRHAGE INTRACRANIAL 28 0.0019
602 INTESTINAL PERFORATION 21 0.0019
603 COVID-19 PNEUMONIA 22 0.0019
604 HERNIA 36 0.0019
605 FRACTURE 35 0.0018
606 CELLULITIS 93 0.0018
607 BLOOD URINE PRESENT 35 0.0018
608 ACCIDENT 22 0.0018
609 HYPERTENSION 389 0.0018
610 PRODUCT PRESCRIBING ISSUE 40 0.0018
611 APPLICATION SITE ERYTHEMA 48 0.0018
612 EOSINOPHILIA 32 0.0018
613 PRODUCT SUBSTITUTION ISSUE 105 0.0018
614 NAUSEA 1443 0.0018
615 VERTIGO 111 0.0018
616 SKIN ULCER 47 0.0018
617 ROAD TRAFFIC ACCIDENT 76 0.0018
618 PULMONARY MASS 27 0.0018
619 FATIGUE 1410 0.0018
620 PLEURAL EFFUSION 110 0.0018
621 CHOLELITHIASIS 59 0.0018
622 APHONIA 25 0.0018
623 RENAL FAILURE ACUTE 76 0.0018
624 BACK DISORDER 29 0.0018
625 INCREASED APPETITE 34 0.0018
626 LEUKOCYTOSIS 32 0.0018
627 CONVULSION 101 0.0018
628 PLATELET COUNT INCREASED 23 0.0018
629 WITHDRAWAL SYNDROME 74 0.0018
630 ULCER 28 0.0018
631 RED BLOOD CELL COUNT DECREASED 50 0.0017
632 HAEMORRHOIDS 34 0.0017
633 PRODUCTIVE COUGH 83 0.0017
634 JOINT STIFFNESS 45 0.0017
635 SUICIDE ATTEMPT 104 0.0017
636 MYDRIASIS 22 0.0017
637 CATARACT 102 0.0017
638 HOSPITALISATION 263 0.0017
639 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 89 0.0017
640 GASTROINTESTINAL HAEMORRHAGE 142 0.0017
641 VENTRICULAR TACHYCARDIA 28 0.0017
642 HAEMOGLOBIN DECREASED 174 0.0017
643 BLOOD CALCIUM DECREASED 19 0.0017
644 RESPIRATORY TRACT INFECTION 44 0.0017
645 DEVICE RELATED INFECTION 26 0.0017
646 GASTRIC ULCER 32 0.0017
647 PAIN IN EXTREMITY 495 0.0017
648 COMA 80 0.0017
649 GASTRITIS 44 0.0017
650 HYPOGLYCAEMIA 81 0.0017
651 RENAL FAILURE 221 0.0017
652 KNEE ARTHROPLASTY 35 0.0017
653 GASTRIC DISORDER 57 0.0017
654 NEPHROLITHIASIS 76 0.0017
655 DRUG INTOLERANCE 160 0.0017
656 PULMONARY OEDEMA 74 0.0017
657 BLOOD CHOLESTEROL INCREASED 77 0.0017
658 INJURY 116 0.0016
659 THERAPY NON-RESPONDER 74 0.0016
660 ABDOMINAL PAIN 381 0.0016
661 STAPHYLOCOCCAL INFECTION 54 0.0016
662 GASTROINTESTINAL PAIN 18 0.0016
663 DRUG DISPENSING ERROR 25 0.0016
664 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
665 LACRIMATION INCREASED 49 0.0016
666 DRUG TOXICITY 22 0.0016
667 LOCALISED INFECTION 39 0.0016
668 ORAL PAIN 36 0.0016
669 RECTAL HAEMORRHAGE 69 0.0016
670 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
671 SKIN INFECTION 18 0.0016
672 STATUS EPILEPTICUS 18 0.0016
673 SARS-COV-2 TEST POSITIVE 21 0.0016
674 SKIN DISCOLOURATION 73 0.0016
675 VISION BLURRED 217 0.0016
676 BACK PAIN 367 0.0016
677 HAEMATEMESIS 40 0.0016
678 PULMONARY EMBOLISM 149 0.0016
679 BURSITIS 19 0.0016
680 COAGULOPATHY 26 0.0016
681 GASTROENTERITIS VIRAL 28 0.0015
682 ABDOMINAL DISCOMFORT 260 0.0015
683 DYSPNOEA 877 0.0015
684 TOOTH FRACTURE 17 0.0015
685 FOOT FRACTURE 29 0.0015
686 NERVE INJURY 17 0.0015
687 DISCOMFORT 93 0.0015
688 DISEASE PROGRESSION 180 0.0015
689 PRODUCT DOSE OMISSION IN ERROR 43 0.0015
690 VOMITING 713 0.0015
691 NEUROPATHY PERIPHERAL 144 0.0015
692 HYPOAESTHESIA 226 0.0015
693 MACULAR DEGENERATION 18 0.0015
694 GASTROINTESTINAL DISORDER 135 0.0015
695 COLITIS 57 0.0015
696 WOUND 42 0.0015
697 RHINORRHOEA 97 0.0015
698 THERAPY CESSATION 77 0.0015
699 BRONCHITIS 111 0.0015
700 CARDIOMYOPATHY 22 0.0015
701 VISUAL IMPAIRMENT 184 0.0015
702 DYSPEPSIA 146 0.0015
703 SEASONAL ALLERGY 21 0.0015
704 NERVOUS SYSTEM DISORDER 46 0.0015
705 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
706 HOT FLUSH 111 0.0015
707 BACK INJURY 16 0.0015
708 CARDIAC ARREST 121 0.0015
709 TENDON RUPTURE 18 0.0015
710 LOWER RESPIRATORY TRACT INFECTION 66 0.0014
711 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 294 0.0014
712 OSTEOPENIA 22 0.0014
713 RESPIRATORY TRACT CONGESTION 23 0.0014
714 THROAT TIGHTNESS 39 0.0014
715 PULMONARY CONGESTION 19 0.0014
716 CHEST PAIN 266 0.0014
717 ARRHYTHMIA 68 0.0014
718 FLUID RETENTION 73 0.0014
719 LUNG DISORDER 70 0.0014
720 CHOLECYSTITIS 17 0.0014
721 KIDNEY INFECTION 28 0.0014
722 INTENTIONAL PRODUCT MISUSE 124 0.0014
723 RESPIRATORY ARREST 39 0.0014
724 CARDIAC FAILURE 113 0.0014
725 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100 0.0014
726 DRUG ADMINISTRATION ERROR 43 0.0014
727 CARDIAC DISORDER 131 0.0014
728 HYPERKALAEMIA 49 0.0014
729 OVERDOSE 301 0.0014
730 BLOOD CREATININE INCREASED 91 0.0014
731 FLATULENCE 79 0.0014
732 CEREBRAL INFARCTION 34 0.0014
733 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
734 OSTEOPOROSIS 57 0.0014
735 DEVICE DEFECTIVE 24 0.0014
736 MUSCLE SPASTICITY 17 0.0014
737 PALPITATIONS 162 0.0014
738 SWOLLEN TONGUE 43 0.0014
739 PAIN IN JAW 39 0.0014
740 MUSCULOSKELETAL PAIN 72 0.0014
741 BODY TEMPERATURE INCREASED 28 0.0014
742 OXYGEN SATURATION DECREASED 77 0.0014
743 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
744 TOOTH INFECTION 18 0.0014
745 ERECTILE DYSFUNCTION 35 0.0014
746 CHOLESTASIS 26 0.0014
747 DYSPNOEA EXERTIONAL 51 0.0014
748 BASAL CELL CARCINOMA 21 0.0013
749 COLON CANCER 20 0.0013
750 JAUNDICE 36 0.0013
751 EXTRA DOSE ADMINISTERED 54 0.0013
752 INTENTIONAL DOSE OMISSION 38 0.0013
753 FREQUENT BOWEL MOVEMENTS 36 0.0013
754 TASTE DISORDER 27 0.0013
755 CHEST DISCOMFORT 136 0.0013
756 TOOTHACHE 24 0.0013
757 TACHYPNOEA 18 0.0013
758 HYPOCALCAEMIA 25 0.0013
759 ABSCESS 21 0.0013
760 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 237 0.0013
761 INFECTION 190 0.0013
762 CORONARY ARTERY OCCLUSION 18 0.0013
763 APPLICATION SITE RASH 18 0.0013
764 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
765 EPILEPSY 40 0.0013
766 DEEP VEIN THROMBOSIS 85 0.0013
767 FLUID OVERLOAD 19 0.0013
768 ABDOMINAL PAIN LOWER 33 0.0013
769 PRODUCT USE ISSUE 244 0.0013
770 PARAESTHESIA 204 0.0013
771 ORAL CANDIDIASIS 17 0.0013
772 ISCHAEMIC STROKE 23 0.0013
773 EMOTIONAL DISTRESS 156 0.0013
774 COVID-19 226 0.0013
775 INCORRECT DOSE ADMINISTERED 294 0.0013
776 THIRST 23 0.0013
777 SKIN HAEMORRHAGE 19 0.0013
778 MUSCULOSKELETAL DISCOMFORT 22 0.0013
779 HYPOACUSIS 55 0.0013
780 OEDEMA 69 0.0013
781 BURNING SENSATION 89 0.0013
782 ANAEMIA 241 0.0013
783 BONE DISORDER 23 0.0013
784 LIP SWELLING 42 0.0013
785 PNEUMOTHORAX 20 0.0013
786 HYPOAESTHESIA ORAL 19 0.0013
787 HYPOKALAEMIA 58 0.0013
788 DYSGEUSIA 93 0.0013
789 EYE DISORDER 41 0.0012
790 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
791 CANDIDA INFECTION 21 0.0012
792 GASTROENTERITIS 18 0.0012
793 THYROID DISORDER 19 0.0012
794 HEART RATE INCREASED 122 0.0012
795 THERAPY INTERRUPTED 88 0.0012
796 BLISTER 69 0.0012
797 GOUT 22 0.0012
798 PROCEDURAL PAIN 34 0.0012
799 DRUG DOSE OMISSION 202 0.0012
800 CARDIO-RESPIRATORY ARREST 51 0.0012
801 PAIN 742 0.0012
802 ARTHRITIS 95 0.0012
803 TOOTH LOSS 25 0.0012
804 LACTIC ACIDOSIS 39 0.0012
805 EXPIRED PRODUCT ADMINISTERED 40 0.0012
806 ACCIDENTAL OVERDOSE 44 0.0012
807 MYOCARDIAL INFARCTION 208 0.0012
808 PANCREATITIS 63 0.0012
809 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
810 DEAFNESS 31 0.0012
811 NIGHT SWEATS 38 0.0012
812 BACTERIAL INFECTION 22 0.0012
813 TINNITUS 54 0.0012
814 DEVICE DELIVERY SYSTEM ISSUE 32 0.0012
815 PERICARDIAL EFFUSION 27 0.0012
816 ACUTE KIDNEY INJURY 178 0.0012
817 SKIN CANCER 25 0.0012
818 SURGERY 68 0.0012
819 HYPOTHYROIDISM 37 0.0012
820 DIVERTICULITIS 32 0.0012
821 ANGINA PECTORIS 33 0.0012
822 JOINT SWELLING 139 0.0012
823 DRUG LEVEL INCREASED 19 0.0011
824 DRY EYE 57 0.0011
825 ARTHROPATHY 63 0.0011
826 ABDOMINAL PAIN UPPER 233 0.0011
827 LYMPHOCYTE COUNT DECREASED 20 0.0011
828 MYALGIA 192 0.0011
829 HEPATIC STEATOSIS 21 0.0011
830 C-REACTIVE PROTEIN INCREASED 41 0.0011
831 TOOTH DISORDER 25 0.0011
832 PHOTOPHOBIA 21 0.0011
833 WEIGHT INCREASED 250 0.0011
834 CIRCULATORY COLLAPSE 19 0.0011
835 TACHYCARDIA 98 0.0011
836 FLUSHING 112 0.0011
837 TENDONITIS 17 0.0011
838 PULMONARY FIBROSIS 21 0.0011
839 THERAPY PARTIAL RESPONDER 17 0.0011
840 ILLNESS 112 0.0011
841 FACE OEDEMA 18 0.0011
842 DISABILITY 21 0.0011
843 SWELLING 98 0.0010
844 HYPERGLYCAEMIA 38 0.0010
845 DRUG PRESCRIBING ERROR 20 0.0010
846 INTENTIONAL SELF-INJURY 21 0.0010
847 NASAL CONGESTION 61 0.0010
848 PYREXIA 359 0.0010
849 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
850 DIARRHOEA 668 0.0010
851 NEUROTOXICITY 18 0.0010
852 PANCREATITIS ACUTE 23 0.0010
853 BLOOD GLUCOSE DECREASED 49 0.0010
854 THROMBOSIS 82 0.0010
855 EPISTAXIS 76 0.0010
856 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
857 EAR INFECTION 27 0.0010
858 CHRONIC KIDNEY DISEASE 77 0.0010
859 BLINDNESS 41 0.0010
860 IMPAIRED HEALING 33 0.0010
861 INTENTIONAL OVERDOSE 64 0.0010
862 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
863 END STAGE RENAL DISEASE 18 0.0010
864 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
865 ERUCTATION 19 0.0010
866 DEVICE USE ERROR 34 0.0010
867 RASH PRURITIC 53 0.0010
868 EAR PAIN 19 0.0010
869 LOCAL SWELLING 17 0.0010
870 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
871 HAEMOPTYSIS 27 0.0010
872 RASH ERYTHEMATOUS 46 0.0010
873 VIRAL INFECTION 32 0.0010
874 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
875 SKIN DISORDER 32 0.0010
876 INFLUENZA 106 0.0009
877 SKIN LESION 26 0.0009
878 HEADACHE 592 0.0009
879 HERPES ZOSTER 54 0.0009
880 CHILLS 110 0.0009
881 SNEEZING 21 0.0009
882 DIABETES MELLITUS 71 0.0009
883 ARTHRALGIA 385 0.0009
884 TYPE 2 DIABETES MELLITUS 31 0.0009
885 PRODUCT USE IN UNAPPROVED INDICATION 227 0.0009
886 DRUG ABUSE 76 0.0009
887 SEPTIC SHOCK 39 0.0009
888 PRODUCT ADHESION ISSUE 32 0.0009
889 GLOSSODYNIA 20 0.0009
890 SWELLING FACE 58 0.0009
891 PRURITUS GENERALISED 19 0.0009
892 OROPHARYNGEAL PAIN 81 0.0009
893 BONE PAIN 51 0.0009
894 LIVER FUNCTION TEST ABNORMAL 25 0.0009
895 RENAL DISORDER 40 0.0009
896 HAEMATOCHEZIA 47 0.0009
897 ERYTHEMA 175 0.0009
898 RASH GENERALISED 22 0.0008
899 VISUAL ACUITY REDUCED 28 0.0008
900 INJECTION SITE MASS 31 0.0008
901 INTENTIONAL PRODUCT USE ISSUE 73 0.0008
902 ALANINE AMINOTRANSFERASE INCREASED 51 0.0008
903 PERITONITIS 17 0.0008
904 INCORRECT DRUG ADMINISTRATION DURATION 23 0.0008
905 METABOLIC ACIDOSIS 26 0.0008
906 THROMBOCYTOPENIA 90 0.0008
907 RASH MACULAR 28 0.0008
908 ANHEDONIA 21 0.0008
909 WHEEZING 47 0.0008
910 HYPERSENSITIVITY 147 0.0008
911 LEUKOPENIA 39 0.0008
912 NEOPLASM MALIGNANT 52 0.0008
913 INFLAMMATION 40 0.0008
914 HAEMORRHAGE 81 0.0008
915 OSTEONECROSIS OF JAW 19 0.0008
916 SKIN IRRITATION 35 0.0008
917 NASOPHARYNGITIS 140 0.0008
918 RASH 329 0.0008
919 DRUG WITHDRAWAL SYNDROME 66 0.0008
920 BLOOD BILIRUBIN INCREASED 20 0.0007
921 SHOCK 17 0.0007
922 PRODUCT QUALITY ISSUE 100 0.0007
923 PNEUMONITIS 20 0.0007
924 OFF LABEL USE 637 0.0007
925 OCULAR HYPERAEMIA 34 0.0007
926 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
927 EYE PAIN 39 0.0007
928 RENAL IMPAIRMENT 57 0.0007
929 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
930 RENAL INJURY 20 0.0007
931 CARDIOVASCULAR DISORDER 17 0.0007
932 PRURITUS 253 0.0007
933 FIBROMYALGIA 16 0.0007
934 TOXICITY TO VARIOUS AGENTS 110 0.0007
935 LYMPHADENOPATHY 23 0.0006
936 INFLUENZA LIKE ILLNESS 53 0.0006
937 LABORATORY TEST ABNORMAL 19 0.0006
938 STOMATITIS 39 0.0006
939 SINUSITIS 65 0.0006
940 FUNGAL INFECTION 21 0.0006
941 PLATELET COUNT DECREASED 66 0.0006
942 WHITE BLOOD CELL COUNT DECREASED 67 0.0006
943 INJECTION SITE ERYTHEMA 76 0.0006
944 INJECTION SITE PRURITUS 41 0.0006
945 LIVER DISORDER 27 0.0006
946 ASTHMA 67 0.0006
947 ECZEMA 31 0.0006
948 NEUTROPHIL COUNT DECREASED 24 0.0006
949 MIGRAINE 56 0.0006
950 BLOOD GLUCOSE INCREASED 109 0.0006
951 EYE SWELLING 21 0.0006
952 INJECTION SITE BRUISING 45 0.0006
953 HEPATIC FAILURE 17 0.0006
954 NO ADVERSE EVENT 102 0.0006
955 LUNG NEOPLASM MALIGNANT 23 0.0006
956 SKIN EXFOLIATION 46 0.0005
957 ASCITES 16 0.0005
958 EYE IRRITATION 31 0.0005
959 PLASMA CELL MYELOMA 21 0.0005
960 HEPATIC FUNCTION ABNORMAL 20 0.0005
961 INCORRECT ROUTE OF DRUG ADMINISTRATION 19 0.0005
962 HEPATIC ENZYME INCREASED 36 0.0005
963 ALOPECIA 103 0.0005
964 COMPLETED SUICIDE 43 0.0005
965 EYE PRURITUS 17 0.0005
966 DISEASE RECURRENCE 24 0.0005
967 NEUTROPENIA 67 0.0005
968 DEVICE MALFUNCTION 34 0.0005
969 URTICARIA 81 0.0005
970 PANCYTOPENIA 27 0.0005
971 DEPENDENCE 25 0.0005
972 PROSTATE CANCER 36 0.0004
973 INTERSTITIAL LUNG DISEASE 21 0.0004
974 PRODUCT STORAGE ERROR 37 0.0004
975 MULTIPLE SCLEROSIS 20 0.0004
976 INJECTION SITE SWELLING 32 0.0004
977 COLITIS ULCERATIVE 18 0.0004
978 DRY SKIN 53 0.0004
979 MULTIPLE SCLEROSIS RELAPSE 27 0.0004
980 INJECTION SITE REACTION 27 0.0004
981 ANAPHYLACTIC REACTION 21 0.0004
982 PSORIASIS 49 0.0004
983 INJECTION SITE HAEMORRHAGE 29 0.0004
984 TREATMENT FAILURE 30 0.0004
985 DEVICE EXPULSION 23 0.0004
986 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
987 DRUG DEPENDENCE 45 0.0003
988 INJECTION SITE PAIN 81 0.0003
989 SKIN BURNING SENSATION 18 0.0003
990 RHEUMATOID ARTHRITIS 28 0.0002
991 BREAST CANCER 18 0.0002
992 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002